There has been a great deal of confusion in the terms used to describe different types of vascular lesions or birthmarks. In the past, the word hemangioma has been used to describe a variety of lesions with differing origins and characteristics. A new classification system was published in 1982 by Mulliken and Glowacki, designed to simplify the nomenclature based on cellular biology with diagnostic applicability to the natural progression of these birthmarks. In this system, vascular birthmarks are divided into two major categories: hemangiomas and malformations. Hemangiomas are the vascular tumors that demonstrate rapid cell turnover or proliferation. Malformations are all other vascular tumors which have a normal endothelial cell turnover or cycle. This article discusses the diagnosis, clinical course, and treatment of hemangiomas.



Five year old with large hemangioma tip of nose

Postoperative result after excision of hemangioma nose and closure with advancement flaps




Hemangiomas are the most common tumors found in infants. Of all newborns, approximately 1% to 3% have hemangiomas. Most hemangiomas are not noted at birth but do appear several weeks later with an incidence of 10% to 12% by 1 year of age. Females are more commonly affected than males by a ratio of 3 to 1. Of the infants diagnosed with a hemangioma, 15% to 20% will have multiple lesions. The first sign of a hemangioma is an erythematous patch or small telangiectasia surrounded by a pale halo. The most common area on the body appears to be the head and neck region.

Clinical Course

Hemangiomas characteristically go through stages of rapid proliferation followed by spontaneous slow involution. These may begin as a “herald spot”, which is a small, well-demarcated pale patch, an erythematous macular patch, or a small area of telangiectasia sur­ rounded by a pale halo. Hemangiomas usually go through their growth phase during the first 8 months of life. The exact time of involution is variable but may start by 18 months of age. Large series of hemangiomas that have been reported show that by age 5, 50% have totally resolved and by age 7, 75% to 90% have disappeared. The size nor the site of the hemangioma has any effect on the time or degree of involution. The lesions that have the best results are ones that have significantly involuted by the age of 5. One of the first signs of involution is the changing of the bright red color to a darker red. The may be followed by a gray appearance to the sur­ face with small white spots appearing. The skin becomes less tense with wrinkling as the lesion involutes.


The majority of hemangiomas will involute and should be permitted to regress spontaneously. However, even with total involution of the hemangioma, the return of the skin to normal is rare. Some hemangiomas can cause problems with function and should then be evaluated for active or early treatment.


A lesion that results in blockage of the airway, visual fields, or ear canal should receive immediate treatment. Other problems such as the massive growth of a facial lesion, large ulceration, and bleeding, or multiple hemangiomas causing congestive heart failure should be considered for treatment. The most common forms of treatment involve steroid therapy, oral propranolol or operative excision. Reported studies have shown that oral steroids may accelerate the start of involution in hemangiomas that are rapidly expanding. Good to excellent results have been achieved by authors in 50% to 90% with oral steroids. Infants less than 6 months of age tend to be more responsive than older patients. When we feel the treatment of a hemangioma is indicated, we give an oral dose of Prednisone at 3-5 mg/kg/1 day for 6-8 weeks. A response should be noted during this time period. In the past 5-7 years, oral propranolol has gained popularity in the successful treatment of capillary hemangiomas as well. In our experience, complications from such treatment are rare.


Operative treatment is usually limited to contouring of the skin after the lesion has involuted. The psychological impact of hemangioma on the face may become a factor in the child starting school. We, therefore, feel that in certain patients, excision of the hemangioma may be indicated or beneficial. Hemangiomas of the tip of the nose may be such lesions. Larger lesions that have not involuted by the time the child starts school should also be considered for excision. The type and extent of excision is based on judgment and experience with careful placement of scars and consideration of long-term aesthetic results.

Contact Us!

American Society of Plastic Surgeons
American Society of Maxiofacial Surgeons
American Society For Aesthetic Plastic Surgery
American Society of Craniofacial Surger
International Society of Craniofacial Surgery
American Associatin of Plastic Surgeons

Sargent Craniofacial Surgery

2290 Ogletree Ave Suite 112

  Chattanooga, Tn 37421   

                423 305-7274                         Fax- 423 206-2826           

  • Facebook Cleft and Craniofacial Utah
  • YouTube Cleft and Craniofacial Utah

Web Application by Med-10

All information provided on this website, either via email, contact forms, and/or booking is done so in compliance with the 2013 "high-tech Act" Omnibus amendment to The Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA, Title II)

© Copyright Cleft and CranioFacial Center Utah™, No reproduction of any kind is allowed in regards to any and all Images, Text, Descriptions, Research, Publications, Names,Persons, or property associated with this website.